Therapeutic Genome Editing Congress - Vendor


Event Pass Information

Event Pass Type

Event Details

The Therapeutic Genome Editing Congress will bring together peers from biotech, technology developers, pharma, academia, along with experts from government bodies, medical institutions and commercial consultants, to discuss how to actively progress clinical development, latest innovations in delivery, technology to eliminate off-targets and reach market approval within genome editing. The conference will cover key industry trends including:

  • Case studies of therapeutic genome editing in clinical trials status (Zinger Finger Nucleases, TALENS and CRISPR/Cas)
  • Technology developments such as base editing to improve the safety if CRISPR
  • Delivery systems optimisation for in vivo applications
  • Potential efficacy issues from patient diversity
  • Commercial factors including, IP, manufacturing and hospital implementation